Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Randomized phase II trial to compare the effectiveness of two different doses of
capecitabine in treating women who have advanced or metastatic breast cancer.